Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...
By designing a squaric acid amide that binds a new site on ATP synthase, researchers created PRP020, a potential therapy for ...
A quick revision guide covering key concepts, biomolecules, cell organelles, and essential NEET-style MCQs to boost exam ...
That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...
Researchers from CIIMAR and the University of Helsinki have discovered a new biochemical modification in natural cyanobacterial products, revealing an unprecedented tool with promising applications in ...
Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...
Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...
Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...
According to management, statistical assessments of the Phase 3 trial points to a very high probability of technical success for regulatory approval of ateganosine. The U.S. Food and Drug ...
LOS ANGELES, CALIFORNIA / ACCESS Newswire / December 11, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback